Ninety-five (85~) of the 112 Japanese patients with systemic lupus erythematosus (SLE) were negative for the complement receptor 1 (CR1) activities on erythrocytes, while 770 (91~) of the 847 normal subjects were positive for CR1, as determined by immune-adherence hemagglutination. Pedigree analyses of the normal population suggested that the phenotype of negative CRI was determined by a autosomal recessive gene. Among 112 SLE patients, 73 (65~) showed persistently negative CR1 during remission for over 26 months of follow-up, although the CR1 levels did vary with the disease activity in 22 SLE patients. These results show that the relative risk for developing SLE in persons with negative CR1 is 19. CR1 activity appears to be an important genetic factor related the development of SLE.
INTRODUCTION
The pathogenesis of systemic lupus erythematosus (SLE) is apparently of multifactorial origin, including hereditary and environmental factors. A genetic predisposition to SLE has been suggested by the epidemiological studies of twins (Block et al., 1975) and by animal models of inbred mice (Hahn, 1987) .
Receptors for the third and fourth components of the activated complement system (complement receptor 1, CR1) are present on erythrocytes, neutrophils, mouocytes, B lymphocytes, some T lymphocytes and renal podocytes (Fearon, 1980; Bianco and Nussenzweig, 1977; Ross, 1979; Wilson et al., 1982a; Gelfand et al., 1975; Kazatchkine et al., 1982) . Although the number of CRI molecules expressed on each red cell is less than 1~ of those on leukocytes, more than 90~ of the total CR1 on the surface of the peripheral blood cells are associated with red cells, because the mass of erythrocytes far exceeds that of leukocytes (Fearon, 1980) . CR1 has a role in processing and clearance of microorganisms coated with C3b/C4b as well as immune complexes (IC), and most of the IC in the circulation is bound on the surface of erythrocytes. Therefore, if the CR1 on the erythrocytes is defective, free IC are not removed from the circulation and possibly cause tissue damage (Siegel et al., 1981; Cornacoff et al., 1983) . Miyakawa et aI. (1981) found that levels of CR1 on erythrocytes were low in patients with SLE. Because the low CR1 levels were persistent in patients irrespective of the disease activity, and because they were observed frequently in family members, the defect would appear to be heritable. Wilson et al. (1982b) estimated the number of CR1 sites on erythrocytes, using a monospecific anti-CR1 antibody. They found that CR1 levels showed a trimodal distribution among the normal population. Thus, CR1 expression was thought to be controlled by two allelic genes, designated high (H) and low (L), and expressed codominantly on the erythrocyte membranes. Iida et al. (1982) noted an increase in CR1 levels on erythrocytes in 2 of the 4 patients with SLE and entering remission. Inada et al. (1982) showed an inverse correlation between CR1 levels and the concentration of immune complexes in the circulation. Moreover, Holme et aI. (1986) pointed out that numbers of CRI were different in each of the two of identical twins with SLE. These reports suggested that the defective CRI was, at least in part, a reversibly changed and acquired condition rather than a genetically determined state.
We report here CR1 levels on erythrocytes from SLE patients and those of normal subjects. The objective of the study was to search for possible genetic factors associated with the development of SLE.
PATIENTS AND METHODS
Patients. We studied 112 Japanese patients with SLE, who had been admitted or who were seen in the clinic of the First Department of Medicine, Kyushu University. The diagnosis of SLE was made according to the revised criteria by American Rheumatism Association (ARA) (Tan et al., 1982) . One hundred and sixty-two workers of a company in Fukuoka city and 685 residents in Yonaguni and Hateruma Islands, Okinawa Prefecture, served as the healthy controls. Family studies were performed for 59 members from the 19 families of probands having SEE and 146 members from the 25 families of normal control subjects.
Immune-Adherence Hemagglutination (IAHA).
The CR1 levels were measured according to the method of IAHA, as described by Miyakawa et al. (1981) . Human lgG was prepared from pooled sera by salt precipitation and chromatography on DEAE-cellulose and was stored at -70~
A solution of IgG in phosphate-buffered saline (10 mg/ml) was heated at 65~ for 30 min. After the precipitates had been removed by centrifugation at 15,000 x g for 15 min, the supernatant was used as the aggregated hmnan 7-globulin (AHG). Serial two-fold dilutions of AHG starting from 100 #g/ml were prepared in a gelatin-veronal-buffer (GVB 2+) in a polystyrene U-bottom microtiter plate. Complement was prepared by dilution of guinea pig serum in GVB 2+ containing 3 CH50 units/ml, 25/11 of which was added to each well. The plate was incubated at 37~ for 45 rain. Thereafter, 25/A of dithiothreitol solution (3 mg/ml) was added to protect the generated C3b sites from decay (Mayumi et al., 1971) . Subsequently, 25 ,,al of erythrocytes suspension (2 x 108 ceils/ ml in EDTA-GVB) was transferred to each well and the plate was incubated at 24~ for further 60 min. The pattern of hemagglutination was observed and the IAHA levels of erythrocytes were expressed by the highest dilution (2 •) of AHG that induced hemagglutination. Figure I illustrates the distribution of IAHA titers of erythrocytes from the l l2 SLE patients and the 847 normal controls. Seventy-three (65~o) SLE patients showed no detectable IAHA levels, 38 patients had titers ranging from 24 to 2 s, and 1 patient had a titer of 21L In contrast to the SLE patients, IAHA titers showed a trimodal distribution in normal controls and only 77 (9~) showed a negative IAHA. No overlaps between positive and negative groups were observed in either SLE patients or the normal controls.
RESULTS

CR1 levels of SLE patients and normal controls
Family study of CR1 levels & the normal population
Among 77 individuals in the normal population with a negative CRI, 25 families were available for pedigree analyses and CRI levels on erythrocytes from 146 members were investigated by IAHA (Fig. 2) . Forty (27~) of the 146 members were negative for CR1 and more than two members had a negative CR1 in 8 families.
CR1 levels of members of SLE families
CR1 levels on erythrocytes from the 59 relatives of 19 SLE patients were assessed by IAHA. As shown in Fig. 3 , clustering of negative CR1 was observed in 9 families. Six (33~) of 18 siblings tested had a negative CR1, thereby indicating that the frequency of negative CR1 is about 3 times higher in siblings of SLE patients than that in normal controls. In one family (Fig. 3B) all members of the proband tested so far have a negative CRI. Here a younger sister of the proband was found to have SLE. The mother showed no clinical symptoms of SLE but the laboratory data were positive for the LE-test, hypergammaglobulinemia as well as leukopenia. She therefore may have had a strong genetic potential to develop SLE. Vol. 33, No. 4, 1988 Relationship between the CR1 levels and disease activity CR1 levels on erythrocytes from 112 SLE patients were followed up for over 26 months. In 22 of the 95 SLE patients who were negative at the initial testing, the CRI level varied with time during the course of the disease. Figure 4 shows the clinical course of a 42-year-old woman with SLE. CR1 levels in this patient were negative at the beginning of the study, and became positive as she went into the remission while on prednisolone.
DISCUSSION
As shown in Fig. 1 , when CR1 levels among the normal controls were depicted as a frequency histogram, 77 (9%) showed negative IAHA, 558 (66%) had titers ranging 2 a to 21~ and 2t2 (25%) had titers of 211. This distribution seemed to be trimodal and suggested the existence of two codominantly expressed alleles that determined high (H) and low (L) levels of CR1 originally proposed by Wilson et al. (1982b) . Persons with high (211) IAHA titers would be homozygous for the high receptor allele and would have the HH phenotype, those with negative IAHA would be homozygous for the low allele and would have the LL phenotype, and those with intermediate (23 to 21~ IAHA titers would be heterozygotes and would have the HL phenotype. However, the expected frequencies of these phenotypes in our Table 1 . Summary of observed phenotypes of a positive and a negative CR1 in 30 families.
Phenotypes of parents P• P•
Phenotypes
Number of of children families (N) 4 (P,P,N) 2 (P,P,P,N) 1 (P,P,N,N) 1 (P,P,P,P,N) 1 (P,P,P,P,P,N) 1 (P) 7 (N) 1 (P,P) 6 (P,N) 2 Vol. 33, No. 4, 1988 normal subjects, as calculated with Hardy-Weinberg equilibrium and assuming this two-codominant-allele model, were 34, 49 and 17~ for HH, HL and LL phenotypes, respectively, and differed significantly from the observed frequencies. The IAHA method was semi-quantitative and there appeared to be overlaps between high (2 ~1) and intermediate (23 to 21~ IAHA titers. Even if IAHA titers higher than 28 were assumed to be HH phenotype, there was a significant difference between expected and observed frequencies. Therefore, we considered that HH and HL phenotypes were indistinguishable by the IAHA method and the frequency histogram of CRI levels among normal controls showed a bimodal distribution. Segregation of a positive and a negative CR1 among 30 families is summarized in Table 1 . The mode of inheritance for a negative CR1 was analyzed by the maximum likelihood scoring method (Morton, 1959) using informative, 29 normal families. The hypothesis that a positive CR1 is controlled by an autosomal recessive gene should be discarded because many children with negative CR1 were segregated from the matings of parents with positive CR1. Moreover, there was a significant difference between observation and expectation (p<0.05) in 17 informative backcross families (Table 2A) . Five informative backcross families were then analyzed assuming the hypothesis of an autosomal recessive gene for a negative CR1. There was no significant difference between observation and expectation in segregation of a negative CR1 in these families (p>0.25), thereby indicating that the hypothesis of an autosomal recessive gene for a negative CR1 cannot be ignored (Table 2B ). The analysis of 10 informative intercross families (p > 0.50) (Table 2C ) also supports this hypothesis. All these data lend credence to the idea that a negative CRI is of a simple recessive character.
If the results of our studies are compared to those reported by Wilson et al. (1982b) , the negative IAHA could correspond to the LL phenotype and the positive IAHA to the HL or HH phenotype. Table 3 shows segregation of the phenotypes in 19 normal families. Data on persons with IAHA titers ranging from 28 to 21~ were ignored because of possible overlaps. Persons with high (211), intermediate (23 to 27) and negative IAHA titers were considered to have HH, HL and LL pheno- This study on CRI levels on erythrocytes in SLE patients suggests that a negative CR1 is a simple recessive character as in the normal population. However, the positive CR1 phenotypes in three families were apparently derived from both parents with a negative CR1 (Fig. 3C) , a finding incompatible with this hypothesis. In 22 of the 95 SLE patients who had a negative CR1 at the initial testing, the levels became positive during the course of the study. Therefore, the negative CR1 in SLE patients seems to be heterogeneous and acquired factors such as disease activity might contribute to the levels of expression of CR1 molecules on erythrocytes. In over a 2 year follow up, 73 (65}/o) of the 112 SLE patients, as compared to 77 (9~) of 847 normal controls, showed a persistently negative CRI. Thus, the major factor responsible for the negative CR1 in SLE patients seems to be a genetic one. Kajiyama (1981) performed an epidemiological study for the purpose of assessing gene-environmental interaction in the development of SLE. He reported that disorders, presumably due to autoimmune mechanisms, hypergammaglobulinemia and unusual immunologic reactions were more frequently found among relatives of SLE patients than in normal individuals and their relatives who served as the controls. Lippman et al. (1982) also investigated genetic factors predisposing to autoimmune disease. Significant differences between relatives and spouses were found in case of occurrence of autoimmune disease, high-titer of antinuclear antibody and antisingle-strand DNA antibody. These observations suggest that genetic rather than environmental factors are more likety to be linked to clinical and serologic differences.
We estimated the relative risk for developing the disease in persons with negative CR1 to be 19, although it was the maximum estimation. CRt on erythrocytes in some cases might be blocked even in a remission. This finding was remarkably high, compared with previously obtained data on HLA antigens and C2 deficiencies that gave the relative risk as between 3 and 6. Erythrocytes CR1 deficiency might cause various immunological disorders regarding liberation of free immune complexes into the circulation. Since a negative CR1 was found to be clustered among SLE patients as well as their relatives, this negative CR1 is assumed to be an important genetic factor linked to the development of SLE.
